ADMA Biologics Announces First Commercial Sales of ASCENIV™
see the press release
ADMA Biologics is a biopharmaceutical company relentlessly committed to creating superior products for immunodeficient patients at risk for infection. It is our devotion to this underserved population that fuels us, and our hands-on approach to production and development that sets us apart.
ADMA Biologics Reports Third Quarter 2019 Financial Results and Highlights Recent Company Progress
ADMA Biologics Reports Third Quarter 2019 Financial Results and Highlights Recent Company Progress:READ MOREADMA Biologics Announces Acceptance to the Plasma Protein Therapeutics Association
ADMA Biologics Announces Acceptance to the Plasma Protein Therapeutics Association:READ MOREADMA Biologics Named Company of the Year by BioFlorida
ADMA Biologics Named Company of the Year by BioFlorida:READ MORE